NEW YORK, March 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Nuclear Medicine Industry
http://www.reportlinker.com/p080450/Global-Nuclear-Medicine-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging
This report analyzes the worldwide markets for Nuclear Medicine in US$ Million by the following Product Segments: Gamma Cameras, and PET Scanners. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 43 companies including many key and niche players such as Digirad Corporation, GE Healthcare Plc, Phillips Healthcare, Inc., Positron Corporation, Siemens Medical Solutions USA, Inc., Toshiba Medical Systems Corporation, and Toshiba America Medical Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Gamma Cameras I-3PET Scanners I-4II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW AND OUTLOOK II-1
Market Snapshots II-1
Nuclear Medicine - An Introduction II-1
Market Witnesses Turbulent Times in Recent Past II-2
Isotope Supply Shock - A Major Factor for Market Decline II-2
Market Rebounds; Brighter Prospects Ahead II-2
Growth Drivers in a Nutshell II-3
Current and Future Analysis II-3
Emerging Markets to Drive Growth; US Still in Spotlight II-4
Susceptibility to Cardiac Disease, Brain Disorders and Cancers
Influence Procedure Volumes II-4
Minimal Impact of Recession on the Medical Contrast Media Market II-4
2. TRENDS AND ISSUES II-5Global Technetium Shortage Eased II-5Market Shifts to Hybrid Imaging II-5PET Eats its Way into Conventional Gamma Camera Market II-6PET-MRI Emerging as a Promising Standard for Imaging SoftTissue Contrast II-6High Costs - A Major Threat for Market Growth II-6Technology Innovations Promise Bright Prospects II-7New Innovations in the Nuclear Medicine Device Market II-7SPECT/CT Scanners Drive Nuclear Medicine Equipment Market inNorth America II-7Global Nuclear Medicine Market - Historic Statistics II-8Table 1: Global Gamma Cameras Market (2006): Installed Basedin Units by Select Country - USA, Japan, Canada, and UK(includes corresponding Graph/Chart) II-8
Table 2: Global PET Scanners Market (2006): Installed Base in
Units by Select Country - USA, Europe, Japan, Germany,
Canada, UK, France, Italy, and Belgium (includes
corresponding Graph/Chart) II-8
3. COMPETITIVE LANDSCAPE II-9Competition Overview in Nuclear Medicine Market II-9Table 3: Leading Players in the Global Gamma Camera Market(2010 & 2011): Percentage Breakdown of Value Sales forPhilips Healthcare, Siemens Healthcare, GE Healthcare, andOthers (includes corresponding Graph/Chart) II-9
Table 4: Leading Players in the Global PET Scanner Market
(2010 & 2011): Percentage Breakdown of Value Sales for
Siemens Healthcare, GE Healthcare, Philips Healthcare and
Others (includes corresponding Graph/Chart) II-10
Leading Players in the Worldwide Nuclear Medicine Market: A
Completive Analysis II-11
4. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW II-12Medical Imaging Changing the Landscape of Clinical Diagnosis II-12Image-Guided Interventions - Driving Growth in NuclearMedicine Arena II-12Understanding the Concept II-12Tremendous Market Potential II-12Clinical Application Areas II-12Diagnostic Imaging Witnesses Dramatic Growth II-13Table 5: Global Medical Imaging Market (2010 & 2011):Percentage Breakdown of Revenues by Imaging Modality - X-Ray,CT, Ultrasound, MRI and PET & PET/CT (includes correspondingGraph/Chart) II-14
Table 6: Global Medical Imaging Equipment Installed Based
(2011): Percentage Share Breakdown by Installed Base for
Medical Equipment: X-ray, Ultrasound, Magnetic Resonance,
Computed Tomography, and Nuclear Medicine/PET by
Country/Region (includes corresponding Graph/Chart) II-15
Comparison of Modalities, by Various Imaging Systems II-15
Medical Imaging Equipment Manufacturers Fine Tune Technologies II-16
Future Growth Prospects for Medical Imaging Equipment Market II-16
Multiple Factors Support Global MRI Equipment Market Growth II-16
Reimbursement Remains the Core Issue II-17
5. NUCLEAR MEDICINE - AN INSIGHT II-18Distinct from General Radiology II-18History II-18Major Developments II-19Nuclear Medicine Scans II-19Bone Scan II-20Brain Scan II-20Gallbladder Scan II-20Kidney Scan II-21Liver Scan II-21Lung Scan II-21Thyroid Scan II-21Scrotal Scan II-21Applications II-22Cardiac Applications II-22Neurologic Applications II-22Oncologic Applications II-22Orthopedic Applications II-22Pulmonary Applications II-23Renal Applications II-23Other Applications II-23Estimated Time Allocations for Nuclear Medicine Procedures II-24Radioisotopes: Essential for Nuclear Medicine Procedure II-24Radioisotopes Used in Medicine II-25Clinical Applications of Select Isotopes II-26Radionuclides in Nuclear Medicine Procedures II-27Positron-Emitting Radionuclides in PET Procedures II-28
6. NUCLEAR MEDICINE IMAGING EQUIPMENT II-29
Gamma Cameras II-29
Positron Emission Tomography (PET) Scanners II-29
Factors Influencing Growth of PET Scanners II-30
PET & Other Imaging Modalities II-30
Table 7: Comparison of PET and Conventional Imaging
Techniques (includes corresponding Graph/Chart) II-31
Brain Imaging II-32
Alzheimer's Disease II-32
Brain Trauma II-32
Epilepsy II-32
Heart Imaging II-32
Mobile PET II-33
Parkinson's Disease II-33
PET & Cancer II-33
PET-CT: An Advancement in Cancer Diagnosis & Treatment II-33
7. RESEARCH AND DEVELOPMENT II-34Researchers Develop Portable PET Scanner, SynchroPET II-34Philips and University Medical Center Hamburg- EppendorfDevelop MRI/PET Imaging Tool II-34Indian Scientists Develop Low-Cost Nuclear Medicine Kit II-34
8. PRODUCT INNOVATIONS/INTRODUCTIONS II-35
Siemens Healthcare to Unveil Biograph mCT 20 Excel, a PET CT
Imager II-35
MEDX Launches T-Quest™ Gamma Camera II-35
Philips Electronics Introduces GEMINI LXL - A PET/CT Scanner II-35
GE Healthcare Unveils PETtrace 880 - A High Capacity Cyclotron II-36
Royal Philips Launches BrightView X - A Mid-level SPECT Camera II-36
Philips Unveils GEMINI TF PET/CT for Oncology Applications II-36
Siemens Introduces c.cam SPECT System II-36
Positron Introduces PosiRx Solution II-37
Naviscan Unveils High-resolution PET Scanner with PEM Biopsy
Capability II-37
Integrated Modular Systems Releases New Version of imsiPACS
Server II-37
9. RECENT INDUSTRY ACTIVITY II-38BC Technical Acquires Xpert II-38GE Healthcare Acquires Orbotech Medical Solutions II-38Comecer Acquires Veenstra Instruments II-38Positron Secures Group Purchasing Agreement from Amerinet II-39GE Healthcare Collaborates with NXT2B II-39Zecotek Inks Development Deal with NuCare II-39Siemens Healthcare receives FDA Clearance for Biograph mCT PETCT Scanner II-40GE Healthcare Receives US FDA Clearance for Brivo NM615 GammaCamera II-40Digirad Inks Deal with Dilon Diagnostics II-40Positron Obtains Approval for Marketing Attrius PET scannersin Canada II-41Royal Philips Electronics Receives US FDA 510(k) Clearance forIngenuity TF PET/MR II-41
10. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER II-42
Hybridyne Obtains FDA Clearance for ProxiScanTM Gamma Camera II-42
Digirad Bags FDA Clearance for Portable Imaging System II-42
Digirad Inks Asset Purchase Agreement with MD Office Solutions II-42
Positron Inks Agency Agreement with TIS II-43
Dilon Diagnostics Inks Agreement with Philips Healthcare II-43
11. FOCUS ON SELECT GLOBAL PLAYERS II-44Digirad Corporation (USA) II-44GE Healthcare Plc (The United Kingdom) II-44Phillips Healthcare, Inc. (USA) II-44Positron Corporation (USA) II-44Siemens Medical Solutions USA, Inc. (USA) II-45Toshiba Medical Systems Corporation (Japan) II-45Toshiba America Medical Systems, Inc. (USA) II-45
12. GLOBAL MARKET PERSPECTIVE II-46
Table 8: World Recent Past, Current & Future Analysis for
Nuclear Medicine by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-46
Table 9: World Historic Review for Nuclear Medicine byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) II-47
Table 10: World 15-Year Perspective for Nuclear Medicine by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) II-48
Nuclear Medicine Market by Product Segment II-49
Table 11: World Recent Past, Current & Future Analysis for
Gamma Cameras by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-49
Table 12: World Historic Review for Gamma Cameras byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) II-50
Table 13: World 15-Year Perspective for Gamma Cameras by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) II-51
Table 14: World Recent Past, Current & Future Analysis for PETScanners by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) II-52
Table 15: World Historic Review for PET Scanners by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) II-53
Table 16: World 15-Year Perspective for PET Scanners byGeographic Region - Percentage Breakdown of Dollar Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan), andRest of World Markets for Years 2004, 2011, & 2018 (includescorresponding Graph/Chart) II-54III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Market Snapshots III-1
Nuclear Medicine Market Drivers and Constraints III-2
Noteworthy Trends and Issues III-2
Nuclear Medicine Market in the US Rebounds in 2011 III-2
The US Market for Nuclear Medicine Driven by Hybrid Modalities III-2
Therapeutic Applications to Drive Growth in the US Nuclear
Medicine Market III-3
Market Witnesses Entry of High Value Products III-3
Adoption of SPECT/CT Increasing in the US III-3
PET Procedures in the US Increase III-4
Nuclear Cardiology: Primary Growth Propellant III-4
Dedicated Cardiac PET Scanners - The Future of Nuclear
Cardiology? III-4
Nuclear Medicine Provision Industry Gradually Moves towards
Consolidation III-5
Correlation between Medical Imaging and Nuclear Medicine III-5
Table 17: US Medical Imaging Market (2011): Percentage
Share Breakdown by Segments - X-Ray Imaging, Contrast
Agent and Injector, MRI, Computed Tomography Imaging,
Ultrasound Imaging and Nuclear Medicine (includes
corresponding Graph/Chart) III-6
Competition III-6
Gamma Cameras III-6
Table 18: Market Share of Leading Players in the US Gamma
Camera Market (2010) (includes corresponding Graph/Chart) III-6
Table 19: Market Share of Leading Players in the US GammaCamera Market by Cardiology Application (2010) (includescorresponding Graph/Chart) III-7PET Scanners III-7Table 20: Leading Players in the US PET Scanner Market(2010 & 2011): Percentage Breakdown of Value Sales forSiemens Medical Solutions, GE Healthcare, PhilipsHealthcare, and Others (includes correspondingGraph/Chart) III-8Regulatory Overview III-8Nuclear Regulatory Commission (NRC) III-8Food and Drug Administration (FDA) III-8Environmental Protection Agency (EPA) III-8Centers for Medicare & Medicaid Services (CMS) III-9Product Launches III-9Strategic Corporate Developments III-10Key Players III-12B.Market Analytics III-14Table 21: US Recent Past, Current & Future Analysis forNuclear Medicine by Product Segment - Gamma Cameras (SingleHead, Dual Head, and Triple Head Cameras) and PET ScannersMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-14
Table 22: US Historic Review for Nuclear Medicine by Product
Segment - Gamma Cameras (Single Head, Dual Head, and Triple
Head Cameras) and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-15
Table 23: US 15-Year Perspective for Nuclear Medicine -Percentage Breakdown of Value Sales for Gamma Cameras(Single Head, Dual Head, and Triple Head Cameras) and PETScanners Markets for Years 2004, 2011, & 2018 (includescorresponding Graph/Chart) III-16
2. CANADA III-17
A.Market Analysis III-17
Current & Future Analysis III-17
Canada Faces Serious Issue over Paucity of PET Scanners III-17
PET Imaging for Cancer Care in Canada - A Long Way to Go III-17
Strategic Corporate Development III-18
B.Market Analytics III-19
Table 24: Canadian Recent Past, Current & Future Analysis
for Nuclear Medicine by Product Segment - Gamma Cameras and
PET Scanners Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-19
Table 25: Canadian Historic Review for Nuclear Medicine byProduct Segment - Gamma Cameras and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-20
Table 26: Canadian 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-21
3. JAPAN III-22A.Market Analysis III-22Current & Future Analysis III-22Market Scenario III-22Production and Exports of Nuclear Medicine Equipment Sufferin Japan III-22Nuclear Medicine Market - Recent Past Statistics III-23Table 27: PET Scanners and Gamma Cameras Market in Japan(2008): Installed Base in Units (includes correspondingGraph/Chart) III-23
Table 28: PET Studies Performed in Japan (2008): Percentage
Breakdown by Type - Tumor, Brain, Heart, and Others
(includes corresponding Graph/Chart) III-23
Table 29: Gamma Cameras Availability in Japan (2007):Percentage Breakdown by Type - Single Head, Dual Head,Triple Head, Quadruple Head, and Ring Type (includescorresponding Graph/Chart) III-23Toshiba Medical Systems Corporation - A Key Japanese Player III-23B.Market Analytics III-24Table 30: Japanese Recent Past, Current & Future Analysisfor Nuclear Medicine by Product Segment - Gamma Cameras andPET Scanners Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) III-24
Table 31: Japanese Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-25
Table 32: Japanese 15-Year Perspective for Nuclear Medicine -Percentage Breakdown of Value Sales for Gamma Cameras andPET Scanners Markets for Years 2004, 2011, & 2018 (includescorresponding Graph/Chart) III-26
4. EUROPE III-27
A.Market Analysis III-27
Current & Future Analysis III-27
Market Overview III-27
Table 33: Leading Therapeutic Areas for Nuclear Medicine
Market in Europe (includes corresponding Graph/Chart) III-28
European Diagnostic Imaging Market III-28
B.Market Analytics III-29
Table 34: European Recent Past, Current & Future Analysis
for Nuclear Medicine by Geographic Region - France, Germany,
Italy, UK, Spain, and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) III-29
Table 35: European Historic Review for Nuclear Medicine byGeographic Region - France, Germany, Italy, UK, Spain, andRest of Europe Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2004 through 2009(includes corresponding Graph/Chart) III-30
Table 36: European 15-Year Perspective for Nuclear Medicine
by Geographic Region - Percentage Breakdown of Dollar Sales
for France, Germany, Italy, UK, Spain, and Rest of Europe
Markets for Years 2004, 2011, & 2018 (includes corresponding
Graph/Chart) III-31
Table 37: European Recent Past, Current & Future Analysisfor Nuclear Medicine by Product Segment - Gamma Cameras(Single Head, Dual Head, and Triple Head Cameras) and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-32
Table 38: European Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras (Single Head, Dual Head, and
Triple Head Cameras) and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-33
Table 39: European 15-Year Perspective for Nuclear Medicine -Percentage Breakdown of Value Sales for Gamma Cameras(Single Head, Dual Head, and Triple Head Cameras), and PETScanners Markets for Years 2004, 2011, & 2018 (includescorresponding Graph/Chart) III-34
4a. FRANCE III-35
Market Analysis III-35
Table 40: French Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-35
Table 41: French Historic Review for Nuclear Medicine byProduct Segment - Gamma Cameras and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-36
Table 42: French 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-37
4b. GERMANY III-38Market Analysis III-38Table 43: German Recent Past, Current & Future Analysis forNuclear Medicine by Product Segment - Gamma Cameras and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-38
Table 44: German Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-39
Table 45: German 15-Year Perspective for Nuclear Medicine -Percentage Breakdown of Value Sales for Gamma Cameras andPET Scanners Markets for Years 2004, 2011, & 2018 (includescorresponding Graph/Chart) III-40
4c. ITALY III-41
A.Market Analysis III-41
Current & Future Analysis III-41
Strategic Corporate Development III-41
B.Market Analytics III-42
Table 46: Italian Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-42
Table 47: Italian Historic Review for Nuclear Medicine byProduct Segment - Gamma Cameras and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-43
Table 48: Italian 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-44
4d. THE UNITED KINGDOM III-45A.Market Analysis III-45Current & Future Analysis III-45Market Overview III-45Table 49: Nuclear Medicine Market in the UK (2011):Percentage Breakdown of Sales by Technology - PlanarImaging, SPECT, PET, Non-Diagnostic Imaging, and Therapy(includes corresponding Graph/Chart) III-45Strategic Corporate Developments III-46GE Healthcare Plc - A Key Player in the UK III-46B.Market Analytics III-47Table 50: UK Recent Past, Current & Future Analysis forNuclear Medicine by Product Segment - Gamma Cameras and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-47
Table 51: UK Historic Review for Nuclear Medicine by Product
Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-48
Table 52: UK 15-Year Perspective for Nuclear Medicine -Percentage Breakdown of Value Sales for Gamma Cameras andPET Scanners Markets for Years 2004, 2011, & 2018 (includescorresponding Graph/Chart) III-49
4e. SPAIN III-50
Market Analysis III-50
Table 53: Spanish Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-50
Table 54: Spanish Historic Review for Nuclear Medicine byProduct Segment - Gamma Cameras and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-51
Table 55: Spanish 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-52
4f. REST OF EUROPE III-53A.Market Analysis III-53Current & Future Analysis III-53Product Launch III-53B.Market Analytics III-54Table 56: Rest of Europe Recent Past, Current & FutureAnalysis for Nuclear Medicine by Product Segment - GammaCameras and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-54
Table 57: Rest of Europe Historic Review for Nuclear
Medicine by Product Segment - Gamma Cameras and PET Scanners
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-55
Table 58: Rest of Europe 15-Year Perspective for NuclearMedicine - Percentage Breakdown of Value Sales for GammaCameras and PET Scanners Markets for Years 2004, 2011, &2018 (includes corresponding Graph/Chart) III-56
5. ASIA-PACIFIC III-57
A.Market Analysis III-57
Current & Future Analysis III-57
Market Overview III-57
Focus On Select Markets III-57
China III-57
Korea III-57
India III-58
Nuclear Medicine Market in India III-58
Table 59: Installed Base of Nuclear Medicine Scanners in
India in 2011 (includes corresponding Graph/Chart) III-58
India Offers High Growth Potential III-58
Competition III-59
Regulatory Mechanism for Guiding Isotope Production and
Distribution III-59
PET/CT Scanning in India Gathers Momentum III-59
Overview of CT Scanners Market in India III-59
Leading Players in the CT Scan Market III-60
Developments in Clinical Practice and Technology III-60
B.Market Analytics III-61
Table 60: Asia-Pacific Recent Past, Current & Future
Analysis for Nuclear Medicine by Product Segment - Gamma
Cameras and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-61
Table 61: Asia-Pacific Historic Review for Nuclear Medicineby Product Segment - Gamma Cameras and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-62
Table 62: Asia-Pacific 15-Year Perspective for Nuclear
Medicine - Percentage Breakdown of Value Sales for Gamma
Cameras and PET Scanners Markets for Years 2004, 2011, &
2018 (includes corresponding Graph/Chart) III-63
6. REST OF WORLD III-64A.Market Analysis III-64Current & Future Analysis III-64Focus on Select Markets III-64The Middle East III-64Latin America III-64B.Market Analytics III-65Table 63: Rest of World Recent Past, Current & FutureAnalysis for Nuclear Medicine by Product Segment - GammaCameras and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2010 through2018 (includes corresponding Graph/Chart) III-65
Table 64: Rest of World Historic Review for Nuclear Medicine
by Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-66
Table 65: Rest of World 15-Year Perspective for NuclearMedicine - Percentage Breakdown of Value Sales for GammaCameras and PET Scanners Markets for Years 2004, 2011, &2018 (includes corresponding Graph/Chart) III-67IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 43 (including Divisions/Subsidiaries - (54)
The United States (34)Canada (1)Japan (5)Europe (8)- Germany (3)- The United Kingdom (1)- Italy (2)- Rest of Europe (2)Asia-Pacific (Excluding Japan) (5)Middle East (1)
To order this report:Therapy Industry: Global Nuclear Medicine Industry
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article